Nomura Holdings
OREX

Nomura Holdings’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Nomura Holdings’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,367
Closed -$75K – 2340
2015
Q4 		$75K Sell
4,367
-172
-4% -$4.1K ﹤0.01% 1740
2015
Q3 		$115K Sell
4,539
-10,033
-69% -$344K ﹤0.01% 1494
2015
Q2 		$740K Buy
14,572
+7,871
+117% +$471K ﹤0.01% 1126
2015
Q1 		$515K Buy
6,701
+5,778
+626% +$358K ﹤0.01% 1073
2014
Q4 		$57K Sell
923
-1,862
-67% -$93.5K ﹤0.01% 2187
2014
Q3 		$124K Buy
+2,785
New +$150K ﹤0.01% 2515
2014
Q1 		– Sell
-3,452
Closed -$194K – 3122
2013
Q4 		$194K Buy
+3,452
New +$194K ﹤0.01% 1764
2013
Q3 		– Sell
-6,124
Closed -$359K – 2917
2013
Q2 		$359K Buy
+6,124
New +$377K ﹤0.01% 1513

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nomura Holdings's OREX Position: Q1 2016 in Review

Nomura Holdings sold out of Orexigen Therapeutics, Inc. (OREX) in Q1 2016, closing a stake of 4,367 shares — an estimated $75K sold.

Nomura Holdings first reported a position in OREX in Q2 2013 and held it in 8 quarters. The position peaked at $740K in Q2 2015. 104 funds tracked by Wall St. Rank hold OREX as of Q1 2016.

  • Nomura Holdings reported no remaining Orexigen Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
  • Nomura Holdings sold 4,367 Orexigen Therapeutics, Inc. shares in Q1 2016, an estimated $75K.
  • Nomura Holdings first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 8 quarters.
  • Nomura Holdings's Orexigen Therapeutics, Inc. position peaked at $740K in Q2 2015.
  • 104 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2016.

Based on Nomura Holdings's 13F filing for Q1 2016, filed 16 May 2016.